Comments on: Neurobiotech company Harmony Biosciences pays $35 million upfront to acquire Epygenix and its epilepsy drug https://lifescivoice.com/neurobiotech-company-harmony-biosciences-pays-35-million-upfront-to-acquire-epygenix-and-its-epilepsy-drug/ Life Sciences Voice | The leading resource for life sciences industry executives. Wed, 01 May 2024 00:35:49 +0000 hourly 1 https://wordpress.org/?v=6.8.1